Our gene expression profiling and subsequent bioinformatic analysis according to the PAM50 and 9-cell line claudin-low predictor [20], [32] revealed that Py2T cells most closely resemble Her2-enriched breast cancer of patients. This evidence concerns the gene ERBB2 and breast carcinoma.